Merck and Ridgeback Biotherapeutics Provide Update on New Clinical and Non-Clinical Studies of LAGEVRIO Life Science Investing
Knight Therapeutics Announces Regulatory Submission for Tafasitamab in Brazil Pharmaceutical Investing
New Study Published in The New England Journal of Medicine Demonstrates Abbott's FreeStyle Libre® 2 System Has Positive Impacts on Glucose Levels and Quality of Life Pharmaceutical Investing
Lobe Sciences Announces the Appointment of Baxter F. Phillips III to Its Board of Directors Pharmaceutical Investing
Seasonal Affective Disorder Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to Prescribers Oct. 1, 2022 Pharmaceutical Investing
Autolus Therapeutics Announces Collaboration with Bristol Myers Squibb for Use of Autolus' Proprietary Safety Switch System Pharmaceutical Investing
Lobe Sciences Announces the Expansion of its Patent Portfolio with International Filings Pharmaceutical Investing
Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference Pharmaceutical Investing
Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
